PL1861713T3 - Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworów - Google Patents

Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworów

Info

Publication number
PL1861713T3
PL1861713T3 PL06727336T PL06727336T PL1861713T3 PL 1861713 T3 PL1861713 T3 PL 1861713T3 PL 06727336 T PL06727336 T PL 06727336T PL 06727336 T PL06727336 T PL 06727336T PL 1861713 T3 PL1861713 T3 PL 1861713T3
Authority
PL
Poland
Prior art keywords
monitoring
early cancer
thereapy
screening
pet tracers
Prior art date
Application number
PL06727336T
Other languages
English (en)
Inventor
Mats Bergstrom
Pasha Razifar
Azita Monnazzam
Orjan Lindhe
Raymond Awad
Bengt Langstrom
Raymond Josephsson
Carl Blomqvist
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of PL1861713T3 publication Critical patent/PL1861713T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nuclear Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL06727336T 2005-03-21 2006-03-20 Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworów PL1861713T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US66381805P 2005-03-21 2005-03-21
US71972605P 2005-09-22 2005-09-22
US78226106P 2006-03-14 2006-03-14
EP06727336A EP1861713B1 (en) 2005-03-21 2006-03-20 Method of screening pet tracers for early cancer thereapy monitoring
PCT/IB2006/000621 WO2006100562A2 (en) 2005-03-21 2006-03-20 Method of screening pet tracers for early cancer thereapy monitoring

Publications (1)

Publication Number Publication Date
PL1861713T3 true PL1861713T3 (pl) 2010-03-31

Family

ID=36727783

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06727336T PL1861713T3 (pl) 2005-03-21 2006-03-20 Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworów

Country Status (10)

Country Link
EP (1) EP1861713B1 (pl)
AT (1) ATE443868T1 (pl)
CY (1) CY1109634T1 (pl)
DE (1) DE602006009380D1 (pl)
DK (1) DK1861713T3 (pl)
ES (1) ES2333669T3 (pl)
PL (1) PL1861713T3 (pl)
PT (1) PT1861713E (pl)
SI (1) SI1861713T1 (pl)
WO (1) WO2006100562A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011082191A1 (en) * 2009-12-30 2011-07-07 Ge Healthcare Limited Method of using a 99mtc-labelled injection rgd compound and a [18f]-labelled rgd injection compound in external beam radiotherapy planning
WO2016061142A1 (en) 2014-10-14 2016-04-21 Novartis Ag Antibody molecules to pd-l1 and uses thereof
CN107847617B (zh) 2015-03-10 2021-08-31 爱默蕾大学 含有取代的亚氨基二乙酸配体的金属三羰基复合物以及作为放射性同位素示踪物的用途
JPWO2019106945A1 (ja) * 2017-11-28 2020-12-17 パナソニックIpマネジメント株式会社 培養状態判定装置、培養状態判定方法及びプログラム
US20240050047A1 (en) * 2020-12-31 2024-02-15 The Board Of Regents Of The University Of Texas System Real-time marker-less dynamic tumor tracking

Also Published As

Publication number Publication date
WO2006100562A3 (en) 2006-11-16
DE602006009380D1 (de) 2009-11-05
ATE443868T1 (de) 2009-10-15
ES2333669T3 (es) 2010-02-25
WO2006100562A2 (en) 2006-09-28
CY1109634T1 (el) 2014-08-13
DK1861713T3 (da) 2010-01-11
PT1861713E (pt) 2009-12-24
SI1861713T1 (sl) 2010-01-29
EP1861713A2 (en) 2007-12-05
EP1861713B1 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
GB2467467B (en) TAZ/WWTR1 for diagnosis and treatment of cancer
GB2472313B (en) Methods of analyzing a selected region of interest in medical image data
WO2006055251A3 (en) Method and apparatus for determining correlation between spatial coordinates in breast
WO2015109263A3 (en) Biomarkers for detecting and monitoring colon cancer
WO2009114117A3 (en) Method and apparatus for emission guided radiation therapy
WO2008103645A3 (en) Prostate cancer and melanoma antigens
Mountzios et al. Developments in the systemic treatment of metastatic cervical cancer
PH12016501206B1 (en) The use of inhibitors of bruton`s tyrosine kinase (btk)
MX2015014486A (es) Marcadores de respuesta de células tumorales a la terapia.
MY188938A (en) Therapeutic, diagnostic and prognostic methods for cancer of the bladder
MX2009006779A (es) Antagonistas especificos para terapia con adyuvantes y neo-adyuvantes y el tratamiento de tumores en etapa temprana.
GB2463819A (en) System and process for detecting, tracking and counting human objects of interest
IL207637A (en) Choosing a Breast Cancer Remedy Using Antibody-Based Arrays
WO2007081767A3 (en) Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
ATE511885T1 (de) Verfahren zur bestimmung eines interessierenden bereiches von oberflächenstrukturen mit einem dosiervolumenhistogramm
NZ703411A (en) Use of markers in the diagnosis and treatment of prostate cancer
MX2017015210A (es) Composiciones y metodos para el cribado de tumores solidos.
MX2014013667A (es) Metodos y sistemas para probar materiales de perdida de circulacion.
GB2535343A (en) Formation evaluation using stochastic analysis of log data
WO2011128792A3 (en) Image data reformatting
WO2006100562A3 (en) Method of screening pet tracers for early cancer thereapy monitoring
GB2465907A (en) VHZ for diagnosis and treatment of cancer
WO2021007525A3 (en) Methods and agents for the detection and treatment of cancer
TW200717203A (en) Method and apparatus capable of indicating elapsed time intervals
WO2011011453A3 (en) Phenotyping tumor-infiltrating leukocytes